PT-141 (Bremelanotide) is a peptide derived from Melanotan II that activates melanocortin receptors to treat sexual dysfunction, including hypoactive sexual desire disorder (HSDD).

PT-141 (Bremelanotide) is a peptide derived from Melanotan II that activates melanocortin receptors to treat sexual dysfunction, including hypoactive sexual desire disorder (HSDD).